183 related articles for article (PubMed ID: 33382762)
1. Point-of-care characterization and risk-based management of oral lesions in primary dental clinics: A simulation model.
Kang SK; Mali RD; Braithwaite RS; Kerr AR; McDevitt J
PLoS One; 2020; 15(12):e0244446. PubMed ID: 33382762
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of screening for oral cancer in primary care.
Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
[TBL] [Abstract][Full Text] [Related]
3. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
4. Computer-assisted analysis of oral brush biopsies at an oral cancer screening program.
Christian DC
J Am Dent Assoc; 2002 Mar; 133(3):357-62. PubMed ID: 11934191
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses.
Awan KH; Morgan PR; Warnakulasuriya S
Oral Oncol; 2011 Apr; 47(4):274-7. PubMed ID: 21396880
[TBL] [Abstract][Full Text] [Related]
7. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group.
Sciubba JJ
J Am Dent Assoc; 1999 Oct; 130(10):1445-57. PubMed ID: 10570588
[TBL] [Abstract][Full Text] [Related]
8. Patients with oral preneoplastic lesions and integration of dental pathology referrals.
Thompson R; Haws J; Rhodus NL; Ondrey FG
Am J Otolaryngol; 2022; 43(1):103270. PubMed ID: 34757252
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the accuracy of diagnoses of oral potentially malignant disorders with dysplasia by a general dental clinician and a specialist using the Taiwanese Nationwide Oral Mucosal Screening Program.
Chiang TE; Lin YC; Wu CT; Yang CY; Wu ST; Chen YW
PLoS One; 2021; 16(1):e0244740. PubMed ID: 33428642
[TBL] [Abstract][Full Text] [Related]
11. Assessing the accuracy of autofluorescence, chemiluminescence and toluidine blue as diagnostic tools for oral potentially malignant disorders--a clinicopathological evaluation.
Awan KH; Morgan PR; Warnakulasuriya S
Clin Oral Investig; 2015 Dec; 19(9):2267-72. PubMed ID: 25804887
[TBL] [Abstract][Full Text] [Related]
12. Oral lichen planus (OLP), oral lichenoid lesions (OLL), oral dysplasia, and oral cancer: retrospective analysis of clinicopathological data from 2002-2011.
Casparis S; Borm JM; Tektas S; Kamarachev J; Locher MC; Damerau G; Grätz KW; Stadlinger B
Oral Maxillofac Surg; 2015 Jun; 19(2):149-56. PubMed ID: 25308326
[TBL] [Abstract][Full Text] [Related]
13. Screening for oral cancer and precancer--a valuable new technique.
Drinnan AJ
Gen Dent; 2000; 48(6):656-60. PubMed ID: 12004660
[TBL] [Abstract][Full Text] [Related]
14. Utility of chemiluminescence (ViziLite™) in the detection of oral potentially malignant disorders and benign keratoses.
Awan KH; Morgan PR; Warnakulasuriya S
J Oral Pathol Med; 2011 Aug; 40(7):541-4. PubMed ID: 21615500
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of light based detection systems for early detection of oral cancer and oral potentially malignant disorders: Systematic review.
Nagi R; Reddy-Kantharaj YB; Rakesh N; Janardhan-Reddy S; Sahu S
Med Oral Patol Oral Cir Bucal; 2016 Jul; 21(4):e447-55. PubMed ID: 26946209
[TBL] [Abstract][Full Text] [Related]
16. Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity--a clinical and histological assessment.
Awan Kh; Yang Y; Morgan P; Warnakulasuriya S
Oral Dis; 2012 Nov; 18(8):728-33. PubMed ID: 22524200
[TBL] [Abstract][Full Text] [Related]
17. Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
Kang SK; Mali RD; Prabhu V; Ferket BS; Loeb S
Radiology; 2021 Sep; 300(3):594-604. PubMed ID: 34254851
[TBL] [Abstract][Full Text] [Related]
18. Inter- and Intra-Observer Variability in Diagnosis of Oral Dysplasia.
R SA; B N P; Hegde U; K U; G S; G K; Sil S
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3251-3254. PubMed ID: 29286215
[TBL] [Abstract][Full Text] [Related]
19. Narrow band (light) imaging of oral mucosa in routine dental patients. Part I: Assessment of value in detection of mucosal changes.
Truelove EL; Dean D; Maltby S; Griffith M; Huggins K; Griffith M; Taylor S
Gen Dent; 2011; 59(4):281-9; quiz 290-1, 319-20. PubMed ID: 21903568
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of oral brush biopsy with computer-assisted analysis in identifying precancerous and cancerous lesions.
Mehrotra R; Mishra S; Singh M; Singh M
Head Neck Oncol; 2011 Aug; 3():39. PubMed ID: 21864339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
